SPDR S&P Pharmaceuticals ETF (XPH)

NYSE Arca: XPHExchange-traded fund from State Street Investment Management.

  • Expense ratio0.35%
  • Net assets$439.0M
  • Dividend yield0.41%
  • 1-year return+28.91%
  • Holdings61

XPH ETF price chart

XPH quote & trading statistics

  • YTD+12.27%
  • 1 year+28.91%
  • 3 years+21.77%/yr
  • 5 years+7.11%/yr
  • 10 years+5.24%/yr
1Y volatility
22.10%
3Y volatility
20.54%
3Y Sharpe ratio
0.76

Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.

XPH top 10 holdings

All holdings →
SPDR S&P Pharmaceuticals ETF largest holdings by weight
#SymbolNameWeight
1MANEVeradermics, Incorporated2.80%
2XERSXeris Pharmaceuticals Inc2.68%
3PCRXPacira BioSciences, Inc.2.56%
4LLYEli Lilly and Company2.42%
5AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock2.42%
6PRGOPerrigo Company PLC2.40%
7MAZEMaze Therapeutics, Inc. Common Stock2.33%
8ZTSZoetis Inc2.27%
9PFEPfizer Inc2.27%
10VTRSViatris Inc2.19%

The top 10 holdings make up 24.3% of the fund (61 holdings in total). As of October 25, 2026.

XPH sector weights

Healthcare
100.0%

XPH region weights

North America
100.0%

XPH asset allocation

U.S. stocks
100.0%
Cash
0.0%

XPH market-cap breakdown

Micro cap
60.5%
Small cap
19.9%
Large cap
8.4%
Mid cap
6.7%
Mega cap
2.4%

About SPDR S&P Pharmaceuticals ETF

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).

XPH ETF FAQ

What is the XPH expense ratio?

SPDR S&P Pharmaceuticals ETF has a net expense ratio of 0.35%, or $35.00 a year for every $10,000 invested.

How much money is in XPH?

SPDR S&P Pharmaceuticals ETF has about $439.0M in net assets.

What are the top holdings of XPH?

The largest positions in XPH are Veradermics, Incorporated (2.80%), Xeris Pharmaceuticals Inc (2.68%), Pacira BioSciences, Inc. (2.56%). The fund holds 61 securities in total.

How has XPH performed?

XPH returned +28.91% over the past year and +7.11% a year over the past five years, including reinvested distributions.

Does XPH pay dividends?

XPH has a dividend yield of 0.41% and pays distributions quarterly.

When was XPH launched?

SPDR S&P Pharmaceuticals ETF began trading on June 19, 2006.